<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39337449</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>18</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>15</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>1-L Transcription in Prion Diseases.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">9961</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms25189961</ELocationID><Abstract><AbstractText>Understanding the pathogenesis and mechanisms of prion diseases can significantly expand our knowledge in the field of neurodegenerative diseases. Prion biology is increasingly recognized as being relevant to the pathophysiology of Alzheimer's disease and Parkinson's disease, both of which affect millions of people each year. This bioinformatics study used a theoretical protein-RNA recognition code (1-L transcription) to reveal the post-transcriptional regulation of the prion protein (PrP<sup>C</sup>). The principle for this method is directly elucidated on PrP<sup>C</sup>, in which an octa-repeat can be 1-L transcribed into a GGA triplet repeat RNA aptamer known to reduce the misfolding of normal PrP<sup>C</sup> into abnormal PrP<sup>Sc</sup>. The identified genes/proteins are associated with mitochondria, cancer, COVID-19 and ER-stress, and approximately half are directly or indirectly associated with prion diseases. For example, the octa-repeat supports CD44, and regions of the brain with astrocytic prion accumulation also display high levels of CD44.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nahalka</LastName><ForeName>Jozef</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-2415-6005</Identifier><AffiliationInfo><Affiliation>Centre for Glycomics, Institute of Chemistry, Slovak Academy of Sciences, Dubravska Cesta 9, SK-84538 Bratislava, Slovakia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre of Excellence for White-Green Biotechnology, Slovak Academy of Sciences, Trieda Andreja Hlinku 2, SK-94976 Nitra, Slovakia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2/0064/22</GrantID><Agency>VEGA</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018621">PrPC Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D052157">Aptamers, Nucleotide</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000072002">Prion Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017096" MajorTopicYN="Y">Prion Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014158" MajorTopicYN="N">Transcription, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018621" MajorTopicYN="N">PrPC Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019295" MajorTopicYN="N">Computational Biology</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D052157" MajorTopicYN="N">Aptamers, Nucleotide</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072002" MajorTopicYN="N">Prion Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">bioinformatics method</Keyword><Keyword MajorTopicYN="N">identified genes</Keyword><Keyword MajorTopicYN="N">post-transcriptional regulation</Keyword><Keyword MajorTopicYN="N">prion diseases</Keyword><Keyword MajorTopicYN="N">protein-RNA recognition</Keyword></KeywordList><CoiStatement>The author declares no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>7</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>29</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39337449</ArticleId><ArticleId IdType="pmc">PMC11431846</ArticleId><ArticleId IdType="doi">10.3390/ijms25189961</ArticleId><ArticleId IdType="pii">ijms25189961</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nahalka J. 1-L Transcription of SARS-CoV-2 Spike Protein S1 Subunit. Int. J. Mol. Sci. 2024;25:4440. doi: 10.3390/ijms25084440.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms25084440</ArticleId><ArticleId IdType="pmc">PMC11049929</ArticleId><ArticleId IdType="pubmed">38674024</ArticleId></ArticleIdList></Reference><Reference><Citation>Nahalka J. 1-L Transcription in Parkinson’s Disease. Front. Biosci. 2023;28:292. doi: 10.31083/j.fbl2811292.</Citation><ArticleIdList><ArticleId IdType="doi">10.31083/j.fbl2811292</ArticleId><ArticleId IdType="pubmed">38062843</ArticleId></ArticleIdList></Reference><Reference><Citation>Nahalka J. 1-L Transcription in Alzheimer’s Disease. Curr. Issues Mol. Biol. 2022;44:3533–3551. doi: 10.3390/cimb44080243.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cimb44080243</ArticleId><ArticleId IdType="pmc">PMC9406503</ArticleId><ArticleId IdType="pubmed">36005139</ArticleId></ArticleIdList></Reference><Reference><Citation>Nahalka J. Transcription of the Envelope Protein by 1-L Protein–RNA Recognition Code Leads to Genes/Proteins That Are Relevant to the SARS-CoV-2 Life Cycle and Pathogenesis. Curr. Issues Mol. Biol. 2022;44:791–816. doi: 10.3390/cimb44020055.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cimb44020055</ArticleId><ArticleId IdType="pmc">PMC8928949</ArticleId><ArticleId IdType="pubmed">35723340</ArticleId></ArticleIdList></Reference><Reference><Citation>Nahalka J. Theoretical Analysis of S, M and N Structural Proteins by the Protein–RNA Recognition Code Leads to Genes/proteins that Are Relevant to the SARS-CoV-2 Life Cycle and Pathogenesis. Front. Genet. 2021;12:763995. doi: 10.3389/fgene.2021.763995.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2021.763995</ArticleId><ArticleId IdType="pmc">PMC8511677</ArticleId><ArticleId IdType="pubmed">34659373</ArticleId></ArticleIdList></Reference><Reference><Citation>Nahalka J. Protein–RNA recognition: Cracking the code. J. Theor. Biol. 2014;343:9–15. doi: 10.1016/j.jtbi.2013.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtbi.2013.11.006</ArticleId><ArticleId IdType="pubmed">24269806</ArticleId></ArticleIdList></Reference><Reference><Citation>Nahalka J. The role of the protein–RNA recognition code in neurodegeneration. Cell. Mol. Life Sci. 2019;76:2043–2058. doi: 10.1007/s00018-019-03096-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-019-03096-3</ArticleId><ArticleId IdType="pmc">PMC11105320</ArticleId><ArticleId IdType="pubmed">30980111</ArticleId></ArticleIdList></Reference><Reference><Citation>Milicevic K., Rankovic B., Andjus P.R., Bataveljic D., Milovanovic D. Emerging Roles for Phase Separation of RNA-Binding Proteins in Cellular Pathology of ALS. Front. Cell Dev. Biol. 2022;10:840256. doi: 10.3389/fcell.2022.840256.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2022.840256</ArticleId><ArticleId IdType="pmc">PMC8965147</ArticleId><ArticleId IdType="pubmed">35372329</ArticleId></ArticleIdList></Reference><Reference><Citation>de Vries T., Novakovic M., Ni Y., Smok I., Inghelram C., Bikaki M., Sarnowski C.P., Han Y., Emmanouilidis L., Padroni G., et al. Specific protein-RNA interactions are mostly preserved in biomolecular condensates. Sci. Adv. 2024;10:eadm7435. doi: 10.1126/sciadv.adm7435.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.adm7435</ArticleId><ArticleId IdType="pmc">PMC10917357</ArticleId><ArticleId IdType="pubmed">38446881</ArticleId></ArticleIdList></Reference><Reference><Citation>Deleauit N.R., Lucassen R.W., Supattapone S. RNA molecules stimulate prion protein conversion. Nature. 2003;425:717–720. doi: 10.1038/nature01979.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature01979</ArticleId><ArticleId IdType="pubmed">14562104</ArticleId></ArticleIdList></Reference><Reference><Citation>Derrington E., Gabus C., Leblanc P., Chnaidermann J., Grave L., Dormont D., Swietnicki W., Morillas M., Marck D., Nandi P., et al. PrPC has nucleic acid chaperoning properties similar to the nucleocapsid protein of HIV-1. Comptes Rendus. Biol. 2002;325:17–23. doi: 10.1016/S1631-0691(02)01388-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1631-0691(02)01388-4</ArticleId><ArticleId IdType="pubmed">11862616</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong J.-M., Munna A.N., Moon J.-H., Kim J.-H., Seol J.-W., Eo S.-K., Park S.-Y. Antiviral activity of prion protein against Japanese encephalitis virus infection in vitro and in vivo. Virus Res. 2023;338:199249. doi: 10.1016/j.virusres.2023.199249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2023.199249</ArticleId><ArticleId IdType="pmc">PMC10598702</ArticleId><ArticleId IdType="pubmed">37858731</ArticleId></ArticleIdList></Reference><Reference><Citation>Mashima T., Nishikawa F., Kamatari Y.O., Fujiwara H., Saimura M., Nagata T., Kodaki T., Nishikawa S., Kuwata K., Katahira M. Anti-prion activity of an RNA aptamer and its structural basis. Nucleic Acids Res. 2012;41:1355–1362. doi: 10.1093/nar/gks1132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gks1132</ArticleId><ArticleId IdType="pmc">PMC3553944</ArticleId><ArticleId IdType="pubmed">23180780</ArticleId></ArticleIdList></Reference><Reference><Citation>Mashima T., Matsugami A., Nishikawa F., Nishikawa S., Katahira M. Unique quadruplex structure and interaction of an RNA aptamer against bovine prion protein. Nucleic Acids Res. 2009;37:6249–6258. doi: 10.1093/nar/gkp647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkp647</ArticleId><ArticleId IdType="pmc">PMC2764455</ArticleId><ArticleId IdType="pubmed">19666719</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamps J., Bader V., Winklhofer K.F., Tatzelt J. Liquid–liquid phase separation of the prion protein is regulated by the octarepeat domain independently of histidines and copper. J. Biol. Chem. 2024;300:107310. doi: 10.1016/j.jbc.2024.107310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2024.107310</ArticleId><ArticleId IdType="pmc">PMC11126799</ArticleId><ArticleId IdType="pubmed">38657863</ArticleId></ArticleIdList></Reference><Reference><Citation>Laurberg M., Asahara H., Korostelev A., Zhu J., Trakhanov S., Noller H.F. Structural basis for translation termination on the 70S ribosome. Nature. 2008;454:852–857. doi: 10.1038/nature07115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature07115</ArticleId><ArticleId IdType="pubmed">18596689</ArticleId></ArticleIdList></Reference><Reference><Citation>Nahalka J., Hrabarova E. Prebiotic Peptides Based on the Glycocodon Theory Analyzed with FRET. Life. 2021;11:380. doi: 10.3390/life11050380.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life11050380</ArticleId><ArticleId IdType="pmc">PMC8146917</ArticleId><ArticleId IdType="pubmed">33922417</ArticleId></ArticleIdList></Reference><Reference><Citation>Lubecka E.A., Hansmann U.H.E. Early Stages of RNA-Mediated Conversion of Human Prions. J. Phys. Chem. B. 2022;126:6221–6230. doi: 10.1021/acs.jpcb.2c04614.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jpcb.2c04614</ArticleId><ArticleId IdType="pmc">PMC9420815</ArticleId><ArticleId IdType="pubmed">35973105</ArticleId></ArticleIdList></Reference><Reference><Citation>Aarum J., Cabrera C.P., Jones A.T., Rajendran S., Adiutori R., Giovannoni G., Barnes M.R., Malaspina A., Sheer D. Enzymatic degradation of RNA causes widespread protein aggregation in cell and tissue lysates. EMBO Rep. 2020;21:e49585. doi: 10.15252/embr.201949585.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201949585</ArticleId><ArticleId IdType="pmc">PMC7534620</ArticleId><ArticleId IdType="pubmed">32945072</ArticleId></ArticleIdList></Reference><Reference><Citation>Zerr I., Ladogana A., Mead S., Hermann P., Forloni G., Appleby B.S. Creutzfeldt–Jakob disease and other prion diseases. Nat. Rev. Dis. Prim. 2024;10:14. doi: 10.1038/s41572-024-00497-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41572-024-00497-y</ArticleId><ArticleId IdType="pubmed">38424082</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L.Q., Zhao K., Yuan H.Y., Wang Q., Guan Z., Tao J., Li X.N., Sun Y., Yi C.W., Chen J., et al. Cryo-EM structure of an amyloid fibril formed by full-length human prion protein. Nat. Struct. Mol. Biol. 2020;27:598–602. doi: 10.1038/s41594-020-0441-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-020-0441-5</ArticleId><ArticleId IdType="pubmed">32514176</ArticleId></ArticleIdList></Reference><Reference><Citation>Hallinan G.I., Ozcan K.A., Hoq R., Cracco L., Vago F.S., Bharath S.R., Li D., Jacobsen M., Doud E.H., Mosley A.L., et al. Cryo-EM structures of prion protein filaments from Gerstmann–Sträussler–Scheinker disease. Acta Neuropathol. 2022;144:509–520. doi: 10.1007/s00401-022-02461-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-022-02461-0</ArticleId><ArticleId IdType="pmc">PMC9381446</ArticleId><ArticleId IdType="pubmed">35819518</ArticleId></ArticleIdList></Reference><Reference><Citation>Lakkaraju A.K.K., Sorce S., Senatore A., Nuvolone M., Guo J., Schwarz P., Moos R., Pelczar P., Aguzzi A. Glial activation in prion diseases is selectively triggered by neuronal PrPSc. Brain Pathol. 2022;32:e13056. doi: 10.1111/bpa.13056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.13056</ArticleId><ArticleId IdType="pmc">PMC9425016</ArticleId><ArticleId IdType="pubmed">35178783</ArticleId></ArticleIdList></Reference><Reference><Citation>Makarava N., Safadi T., Mychko O., Pandit N.P., Molesworth K., Baiardi S., Zhang L., Parchi P., Baskakov I.V. Engulfment of viable neurons by reactive microglia in prion diseases. bioRxiv. 2024 doi: 10.1101/2024.03.06.583759.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2024.03.06.583759</ArticleId></ArticleIdList></Reference><Reference><Citation>Shafiq M., Da Vela S., Amin L., Younas N., Harris D.A., Zerr I., Altmeppen H.C., Svergun D., Glatzel M. The prion protein and its ligands: Insights into structure-function relationships. Biochim. Biophys. Acta (BBA) Mol. Cell Res. 2022;1869:119240. doi: 10.1016/j.bbamcr.2022.119240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2022.119240</ArticleId><ArticleId IdType="pubmed">35192891</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinoshita T. Biosynthesis and biology of mammalian GPI-anchored proteins. Open Biol. 2020;10:190290. doi: 10.1098/rsob.190290.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsob.190290</ArticleId><ArticleId IdType="pmc">PMC7125958</ArticleId><ArticleId IdType="pubmed">32156170</ArticleId></ArticleIdList></Reference><Reference><Citation>Takasugi M., Ohtani N., Takemura K., Emmrich S., Zakusilo F.T., Yoshida Y., Kutsukake N., Mariani J.N., Windrem M.S., Chandler-Militello D., et al. CD44 correlates with longevity and enhances basal ATF6 activity and ER stress resistance. Cell Rep. 2023;42:113130. doi: 10.1016/j.celrep.2023.113130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2023.113130</ArticleId><ArticleId IdType="pmc">PMC10591879</ArticleId><ArticleId IdType="pubmed">37708026</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradford B.M., Wijaya C.A.W., Mabbott N.A. Discrimination of Prion Strain Targeting in the Central Nervous System via Reactive Astrocyte Heterogeneity in CD44 Expression. Front. Cell. Neurosci. 2019;13:411. doi: 10.3389/fncel.2019.00411.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2019.00411</ArticleId><ArticleId IdType="pmc">PMC6746926</ArticleId><ArticleId IdType="pubmed">31551718</ArticleId></ArticleIdList></Reference><Reference><Citation>Amici M., Cecarini V., Cuccioloni M., Angeletti M., Barocci S., Rossi G., Fioretti E., Keller J.N., Eleuteri A.M. Interplay between 20S proteasomes and prion proteins in scrapie disease. J. Neurosci. Res. 2009;88:191–201. doi: 10.1002/jnr.22186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.22186</ArticleId><ArticleId IdType="pubmed">19658198</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai T., Hua B., Luo D., Xu L., Cheng Q., Yuan G., Yan Z., Sun N., Hua L., Lu C. The circadian protein CLOCK regulates cell metabolism via the mitochondrial carrier SLC25A10. Biochim. Biophys. Acta (BBA) Mol. Cell Res. 2019;1866:1310–1321. doi: 10.1016/j.bbamcr.2019.03.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2019.03.016</ArticleId><ArticleId IdType="pubmed">30943427</ArticleId></ArticleIdList></Reference><Reference><Citation>Dossena S., Imeri L., Mangieri M., Garofoli A., Ferrari L., Senatore A., Restelli E., Balducci C., Fiordaliso F., Salio M., et al. Mutant Prion Protein Expression Causes Motor and Memory Deficits and Abnormal Sleep Patterns in a Transgenic Mouse Model. Neuron. 2008;60:598–609. doi: 10.1016/j.neuron.2008.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2008.09.008</ArticleId><ArticleId IdType="pubmed">19038218</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultz J., Schwarz A., Neidhold S., Burwinkel M., Riemer C., Simon D., Kopf M., Otto M., Baier M. Role of Interleukin-1 in Prion Disease-Associated Astrocyte Activation. Am. J. Pathol. 2004;165:671–678. doi: 10.1016/S0002-9440(10)63331-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9440(10)63331-7</ArticleId><ArticleId IdType="pmc">PMC1618583</ArticleId><ArticleId IdType="pubmed">15277240</ArticleId></ArticleIdList></Reference><Reference><Citation>Hafner-Bratkovič I., Benčina M., Fitzgerald K.A., Golenbock D., Jerala R. NLRP3 inflammasome activation in macrophage cell lines by prion protein fibrils as the source of IL-1β and neuronal toxicity. Cell. Mol. Life Sci. 2012;69:4215–4228. doi: 10.1007/s00018-012-1140-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-012-1140-0</ArticleId><ArticleId IdType="pmc">PMC3508391</ArticleId><ArticleId IdType="pubmed">22926439</ArticleId></ArticleIdList></Reference><Reference><Citation>Booth S., Bowman C., Baumgartner R., Dolenko B., Sorensen G., Robertson C., Coulthart M., Phillipson C., Somorjai R. Molecular classification of scrapie strains in mice using gene expression profiling. Biochem. Biophys. Res. Commun. 2004;325:1339–1345. doi: 10.1016/j.bbrc.2004.10.150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2004.10.150</ArticleId><ArticleId IdType="pubmed">15555574</ArticleId></ArticleIdList></Reference><Reference><Citation>Hafiz F.B., Brown D.R. A Model for the Mechanism of Astrogliosis in Prion Disease. Mol. Cell. Neurosci. 2000;16:221–232. doi: 10.1006/mcne.2000.0868.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/mcne.2000.0868</ArticleId><ArticleId IdType="pubmed">10995549</ArticleId></ArticleIdList></Reference><Reference><Citation>Schumacher J.A., Wright Z.A., Florat D.R., Anand S.K., Dasyani M., Batta S.P.R., Laverde V., Ferrari K., Klimkaite L., Bredemeier N.O., et al. SH2 domain protein E and ABL signaling regulate blood vessel size. PLOS Genet. 2024;20:e1010851. doi: 10.1371/journal.pgen.1010851.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1010851</ArticleId><ArticleId IdType="pmc">PMC10798624</ArticleId><ArticleId IdType="pubmed">38190417</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan B., Yang L., Wang J., Wang Y., Wang J., Zhou X., Yin X., Zhang Z., Zhao D. c-Abl Tyrosine Kinase Mediates Neurotoxic Prion Peptide-Induced Neuronal Apoptosis via Regulating Mitochondrial Homeostasis. Mol. Neurobiol. 2014;49:1102–1116. doi: 10.1007/s12035-014-8646-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-014-8646-4</ArticleId><ArticleId IdType="pubmed">24510275</ArticleId></ArticleIdList></Reference><Reference><Citation>Shott R.H., Majer A., Frost K.L., Booth S.A., Schang L.M. Activation of pro-survival CaMK4β/CREB and pro-death MST1 signaling at early and late times during a mouse model of prion disease. Virol. J. 2014;11:160. doi: 10.1186/1743-422X-11-160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-11-160</ArticleId><ArticleId IdType="pmc">PMC4168054</ArticleId><ArticleId IdType="pubmed">25183307</ArticleId></ArticleIdList></Reference><Reference><Citation>Steele A.D., Hutter G., Jackson W.S., Heppner F.L., Borkowski A.W., King O.D., Raymond G.J., Aguzzi A., Lindquist S. Heat shock factor 1 regulates lifespan as distinct from disease onset in prion disease. Proc. Natl. Acad. Sci. USA. 2008;105:13626–13631. doi: 10.1073/pnas.0806319105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0806319105</ArticleId><ArticleId IdType="pmc">PMC2533240</ArticleId><ArticleId IdType="pubmed">18757733</ArticleId></ArticleIdList></Reference><Reference><Citation>Loh X.-Y., Sun Q.-Y., Ding L.-W., Mayakonda A., Venkatachalam N., Yeo M.-S., Silva T.C., Xiao J.-F., Doan N.B., Said J.W., et al. RNA-Binding Protein ZFP36L1 Suppresses Hypoxia and Cell-Cycle Signaling. Cancer Res. 2020;80:219–233. doi: 10.1158/0008-5472.CAN-18-2796.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-18-2796</ArticleId><ArticleId IdType="pubmed">31551365</ArticleId></ArticleIdList></Reference><Reference><Citation>Segal D., Maier S., Mastromarco G.J., Qian W.W., Nabeel-Shah S., Lee H., Moore G., Lacoste J., Larsen B., Lin Z.-Y., et al. A central chaperone-like role for 14-3-3 proteins in human cells. Mol. Cell. 2023;83:974–993. doi: 10.1016/j.molcel.2023.02.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2023.02.018</ArticleId><ArticleId IdType="pubmed">36931259</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamin D., Schmidlin M., Min L., Gross B., Moroni C. BRF1 Protein Turnover and mRNA Decay Activity Are Regulated by Protein Kinase B at the Same Phosphorylation Sites. Mol. Cell. Biol. 2006;26:9497–9507. doi: 10.1128/MCB.01099-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.01099-06</ArticleId><ArticleId IdType="pmc">PMC1698544</ArticleId><ArticleId IdType="pubmed">17030608</ArticleId></ArticleIdList></Reference><Reference><Citation>Leitão M., Baldeiras I., Almeida M., Ribeiro M., Santos A., Tomás J., Rocha S., Santana I., Oliveira C. Sporadic Creutzfeldt–Jakob disease diagnostic accuracy is improved by a new CSF ELISA 14-3-3γ assay. Neuroscience. 2016;322:398–407. doi: 10.1016/j.neuroscience.2016.02.057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2016.02.057</ArticleId><ArticleId IdType="pubmed">26940479</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu W., Edwards M.R., Borek D.M., Feagins A.R., Mittal A., Alinger J.B., Berry K.N., Yen B., Hamilton J., Brett T.J., et al. Ebola Virus VP24 Targets a Unique NLS Binding Site on Karyopherin Alpha 5 to Selectively Compete with Nuclear Import of Phosphorylated STAT1. Cell Host Microbe. 2014;16:187–200. doi: 10.1016/j.chom.2014.07.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2014.07.008</ArticleId><ArticleId IdType="pmc">PMC4188415</ArticleId><ArticleId IdType="pubmed">25121748</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishibashi D., Homma T., Nakagaki T., Fuse T., Sano K., Satoh K., Mori T., Atarashi R., Nishida N. Type I interferon protects neurons from prions in in vivo models. Brain. 2019;142:1035–1050. doi: 10.1093/brain/awz016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz016</ArticleId><ArticleId IdType="pmc">PMC6439327</ArticleId><ArticleId IdType="pubmed">30753318</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasha T., Zatorska A., Sharipov D., Rogelj B., Hortobagyi T., Hirth F. Karyopherin abnormalities in neurodegenerative proteinopathies. Brain. 2021;144:2915–2932. doi: 10.1093/brain/awab201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab201</ArticleId><ArticleId IdType="pmc">PMC8194669</ArticleId><ArticleId IdType="pubmed">34019093</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Q., Huang T. Regulation of the Cell Cycle by ncRNAs Affects the Efficiency of CDK4/6 Inhibition. Int. J. Mol. Sci. 2023;24:8939. doi: 10.3390/ijms24108939.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24108939</ArticleId><ArticleId IdType="pmc">PMC10219488</ArticleId><ArticleId IdType="pubmed">37240281</ArticleId></ArticleIdList></Reference><Reference><Citation>Li G.-S., Chen G., Liu J., Tang D., Zheng J.-H., Luo J., Jin M.-H., Lu H.-S., Bao C.-X., Tian J., et al. Clinical significance of cyclin-dependent kinase inhibitor 2C expression in cancers: From small cell lung carcinoma to pan-cancers. BMC Pulm. Med. 2022;22:246. doi: 10.1186/s12890-022-02036-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12890-022-02036-5</ArticleId><ArticleId IdType="pmc">PMC9233395</ArticleId><ArticleId IdType="pubmed">35751045</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Everbroeck B., Dewulf E., Pals P., Lübke U., Martin J.-J., Cras P. The role of cytokines, astrocytes, microglia and apoptosis in Creutzfeldt-Jakob disease. Neurobiol. Aging. 2001;23:59–64. doi: 10.1016/S0197-4580(01)00236-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0197-4580(01)00236-6</ArticleId><ArticleId IdType="pubmed">11755020</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiang L., Yu W., Andreadis A., Luo M., Baas P.W. Tau Protects Microtubules in the Axon from Severing by Katanin. J. Neurosci. 2006;26:3120–3129. doi: 10.1523/JNEUROSCI.5392-05.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5392-05.2006</ArticleId><ArticleId IdType="pmc">PMC6674103</ArticleId><ArticleId IdType="pubmed">16554463</ArticleId></ArticleIdList></Reference><Reference><Citation>Ermann N., Lewczuk P., Schmitz M., Lange P., Knipper T., Goebel S., Kornhuber J., Zerr I., Llorens F. CSF nonphosphorylated Tau as a biomarker for the discrimination of AD from CJD. Ann. Clin. Transl. Neurol. 2018;5:883–887. doi: 10.1002/acn3.584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.584</ArticleId><ArticleId IdType="pmc">PMC6043772</ArticleId><ArticleId IdType="pubmed">30009207</ArticleId></ArticleIdList></Reference><Reference><Citation>Cali I., Cohen M.L., Haïk S., Parchi P., Giaccone G., Collins S.J., Kofskey D., Wang H., McLean C.A., Brandel J.-P., et al. Iatrogenic Creutzfeldt-Jakob disease with Amyloid-β pathology: An international study. Acta Neuropathol. Commun. 2018;6:5. doi: 10.1186/s40478-017-0503-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-017-0503-z</ArticleId><ArticleId IdType="pmc">PMC5759292</ArticleId><ArticleId IdType="pubmed">29310723</ArticleId></ArticleIdList></Reference><Reference><Citation>Han K.-J., Mikalayeva V., Gerber S.A., Kettenbach A.N., Skeberdis V.A., Prekeris R. Rab40c regulates focal adhesions and PP6 activity by controlling ANKRD28 ubiquitylation. Life Sci. Alliance. 2022;5:e202101346. doi: 10.26508/lsa.202101346.</Citation><ArticleIdList><ArticleId IdType="doi">10.26508/lsa.202101346</ArticleId><ArticleId IdType="pmc">PMC9070665</ArticleId><ArticleId IdType="pubmed">35512830</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanata E., Llorens F., Dafou D., Dimitriadis A., Thüne K., Xanthopoulos K., Bekas N., Espinosa J.C., Schmitz M., Marín-Moreno A., et al. RNA editing alterations define manifestation of prion diseases. Proc. Natl. Acad. Sci. USA. 2019;116:19727–19735. doi: 10.1073/pnas.1803521116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1803521116</ArticleId><ArticleId IdType="pmc">PMC6765247</ArticleId><ArticleId IdType="pubmed">31492812</ArticleId></ArticleIdList></Reference><Reference><Citation>Ber Y., Shiloh R., Gilad Y., Degani N., Bialik S., Kimchi A. DAPK2 is a novel regulator of mTORC1 activity and autophagy. Cell Death Differ. 2014;22:465–475. doi: 10.1038/cdd.2014.177.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2014.177</ArticleId><ArticleId IdType="pmc">PMC4326577</ArticleId><ArticleId IdType="pubmed">25361081</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiloh R., Gilad Y., Ber Y., Eisenstein M., Aweida D., Bialik S., Cohen S., Kimchi A. Non-canonical activation of DAPK2 by AMPK constitutes a new pathway linking metabolic stress to autophagy. Nat. Commun. 2018;9:1759. doi: 10.1038/s41467-018-03907-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-03907-4</ArticleId><ArticleId IdType="pmc">PMC5931534</ArticleId><ArticleId IdType="pubmed">29717115</ArticleId></ArticleIdList></Reference><Reference><Citation>López-Pérez O., Otero A., Filali H., Sanz-Rubio D., Toivonen J.M., Zaragoza P., Badiola J.J., Bolea R., Martín-Burriel I. Dysregulation of autophagy in the central nervous system of sheep naturally infected with classical scrapie. Sci. Rep. 2019;9:1911. doi: 10.1038/s41598-019-38500-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-38500-2</ArticleId><ArticleId IdType="pmc">PMC6374525</ArticleId><ArticleId IdType="pubmed">30760781</ArticleId></ArticleIdList></Reference><Reference><Citation>López-Pérez O., Toivonen J.M., Otero A., Solanas L., Zaragoza P., Badiola J.J., Osta R., Bolea R., Martín-Burriel I. Impairment of autophagy in scrapie-infected transgenic mice at the clinical stage. Mod. Pathol. 2020;100:52–63. doi: 10.1038/s41374-019-0312-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41374-019-0312-z</ArticleId><ArticleId IdType="pubmed">31477795</ArticleId></ArticleIdList></Reference><Reference><Citation>Osipovich A.B., Jennings J.L., Lin Q., Link A.J., Ruley H.E. Dyggve–Melchior–Clausen syndrome: Chondrodysplasia resulting from defects in intracellular vesicle traffic. Proc. Natl. Acad. Sci. USA. 2008;105:16171–16176. doi: 10.1073/pnas.0804259105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0804259105</ArticleId><ArticleId IdType="pmc">PMC2571016</ArticleId><ArticleId IdType="pubmed">18852472</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakurai A., Okamoto K., Fujita Y., Nakazato Y., Wakabayashi K., Takahashi H., Gonatas N.K. Fragmentation of the Golgi apparatus of the ballooned neurons in patients with corticobasal degeneration and Creutzfeldt-Jakob disease. Acta Neuropathol. 2000;100:270–274. doi: 10.1007/s004010000182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004010000182</ArticleId><ArticleId IdType="pubmed">10965796</ArticleId></ArticleIdList></Reference><Reference><Citation>Gossner A.G., Hopkins J. Transcriptome analysis of CNS immediately before and after the detection of PrPSc in SSBP/1 sheep scrapie. Veter. Microbiol. 2014;173:201–207. doi: 10.1016/j.vetmic.2014.07.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vetmic.2014.07.026</ArticleId><ArticleId IdType="pmc">PMC4206282</ArticleId><ArticleId IdType="pubmed">25183238</ArticleId></ArticleIdList></Reference><Reference><Citation>Julius C., Hutter G., Wagner U., Seeger H., Kana V., Kranich J., Klöhn P., Weissmann C., Miele G., Aguzzi A. Transcriptional stability of cultured cells upon prion infection. J. Mol. Biol. 2008;375:1222–1233. doi: 10.1016/j.jmb.2007.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2007.11.003</ArticleId><ArticleId IdType="pubmed">18082765</ArticleId></ArticleIdList></Reference><Reference><Citation>Guizzunti G., Zurzolo C. Cytosolically expressed PrP GPI-signal peptide interacts with mitochondria. Commun. Integr. Biol. 2015;8:e1036206. doi: 10.1080/19420889.2015.1036206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19420889.2015.1036206</ArticleId><ArticleId IdType="pmc">PMC4594234</ArticleId><ArticleId IdType="pubmed">26480298</ArticleId></ArticleIdList></Reference><Reference><Citation>Faris R., Moore R.A., Ward A., Race B., Dorward D.W., Hollister J.R., Fischer E.R., Priola S.A. Cellular prion protein is present in mitochondria of healthy mice. Sci. Rep. 2017;7:41556. doi: 10.1038/srep41556.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep41556</ArticleId><ArticleId IdType="pmc">PMC5288712</ArticleId><ArticleId IdType="pubmed">28148964</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi A., Hirata T., Shimazaki T., Munesue Y., Aoshima K., Kimura T., Nio-Kobayashi J., Hasebe R., Takeuchi A., Matsuura Y., et al. A point mutation in GPI-attachment signal peptide accelerates the development of prion disease. Acta Neuropathol. 2023;145:637–650. doi: 10.1007/s00401-023-02553-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-023-02553-5</ArticleId><ArticleId IdType="pubmed">36879070</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang Q., Kimura Y., Shimazu T., Suzuki T., Yamada A., Dohmae N., Iwasaki S., Shinkai Y. Mammalian HEMK1 methylates glutamine residue of the GGQ motif of mitochondrial release factors. Sci. Rep. 2022;12:4104. doi: 10.1038/s41598-022-08061-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-08061-y</ArticleId><ArticleId IdType="pmc">PMC8904536</ArticleId><ArticleId IdType="pubmed">35260756</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossmann M.P., Dubois S.M., Agarwal S., Zon L.I. Mitochondrial function in development and disease. Dis. Model. Mech. 2021;14:dmm048912. doi: 10.1242/dmm.048912.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.048912</ArticleId><ArticleId IdType="pmc">PMC8214736</ArticleId><ArticleId IdType="pubmed">34114603</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang M., Xie X., Zhu X., Jiang S., Milenkovic D., Misic J., Shi Y., Tandukar N., Li X., Atanassov I., et al. The mitochondrial single-stranded DNA binding protein is essential for initiation of mtDNA replication. Sci. Adv. 2021;7:eabf8631. doi: 10.1126/sciadv.abf8631.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abf8631</ArticleId><ArticleId IdType="pmc">PMC11057760</ArticleId><ArticleId IdType="pubmed">34215584</ArticleId></ArticleIdList></Reference><Reference><Citation>Coppedè F. One-carbon epigenetics and redox biology of neurodegeneration. Free. Radic. Biol. Med. 2020;170:19–33. doi: 10.1016/j.freeradbiomed.2020.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2020.12.002</ArticleId><ArticleId IdType="pubmed">33307166</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P., Geng J., Gao J., Zhao H., Li J., Shi Y., Yang B., Xiao C., Linghu Y., Sun X., et al. Macrophage achieves self-protection against oxidative stress-induced ageing through the Mst-Nrf2 axis. Nat. Commun. 2019;10:755. doi: 10.1038/s41467-019-08680-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-08680-6</ArticleId><ArticleId IdType="pmc">PMC6376064</ArticleId><ArticleId IdType="pubmed">30765703</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumiya R., Terayama M., Hagiwara T., Nakata K., Sekihara K., Nagasaka S., Miyazaki H., Igari T., Yamada K., Kawamura Y.I. Loss of GSTO2 contributes to cell growth and mitochondria function via the p38 signaling in lung squamous cell carcinoma. Cancer Sci. 2021;113:195–204. doi: 10.1111/cas.15189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cas.15189</ArticleId><ArticleId IdType="pmc">PMC8748250</ArticleId><ArticleId IdType="pubmed">34726807</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang B., Shen P., Yin X., Dai Y., Ding M., Cui L. Expression and functions of cellular prion proteins in immunocytes. Scand. J. Immunol. 2020;91:e12854. doi: 10.1111/sji.12854.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/sji.12854</ArticleId><ArticleId IdType="pubmed">31785109</ArticleId></ArticleIdList></Reference><Reference><Citation>Lash L.H. Mitochondrial glutathione transport: Physiological, pathological and toxicological implications. Chem. Interact. 2006;163:54–67. doi: 10.1016/j.cbi.2006.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cbi.2006.03.001</ArticleId><ArticleId IdType="pmc">PMC1621086</ArticleId><ArticleId IdType="pubmed">16600197</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma S., Song Y., Xu Y., Wang C., Yang Y., Zheng Y., Lu Q., Chen Q., Wu J., Wang B., et al. Mild Therapeutic Hypothermia Alleviated Myocardial Ischemia/Reperfusion Injury via Targeting SLC25A10 to Suppress Mitochondrial Apoptosis. J. Cardiovasc. Transl. Res. 2024;17:946–958. doi: 10.1007/s12265-024-10503-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12265-024-10503-z</ArticleId><ArticleId IdType="pmc">PMC11371862</ArticleId><ArticleId IdType="pubmed">38568407</ArticleId></ArticleIdList></Reference><Reference><Citation>Han H., Bearss D.J., Browne L.W., Calaluce R., Nagle R.B., Von Hoff D.D. Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray. Cancer Res. 2002;62:2890–2896.</Citation><ArticleIdList><ArticleId IdType="pubmed">12019169</ArticleId></ArticleIdList></Reference><Reference><Citation>Nahed R.A., Safwan-Zaiter H., Gemy K., Lyko C., Boudaud M., Desseux M., Marquette C., Barjat T., Alfaidy N., Benharouga M. The Multifaceted Functions of Prion Protein (PrPC) in Cancer. Cancers. 2023;15:4982. doi: 10.3390/cancers15204982.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers15204982</ArticleId><ArticleId IdType="pmc">PMC10605613</ArticleId><ArticleId IdType="pubmed">37894349</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang J., Pan Y., Zhang D., Guo C., Shi Y., Wang J., Chen Y., Wang X., Liu J., Guo X., et al. Cellular prion protein promotes proliferation and G1/S transition of human gastric cancer cells SGC7901 and AGS. FASEB J. 2007;21:2247–2256. doi: 10.1096/fj.06-7799com.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.06-7799com</ArticleId><ArticleId IdType="pubmed">17409275</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M.-T., Dong L., Zhang X.-H., Yin X.-L., Ning H.-M., Shen C., Su R., Li F., Song L., Ma Y.-N., et al. ZFP36L1 promotes monocyte/macrophage differentiation by repressing CDK6. Sci. Rep. 2015;5:16229. doi: 10.1038/srep16229.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep16229</ArticleId><ArticleId IdType="pmc">PMC4635361</ArticleId><ArticleId IdType="pubmed">26542173</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding K., Zhang F., Qi G., Lin M.L., Chen M., Chen Y., Zheng J., Zhou F. ZFP36L1 Promotes Gastric Cancer Progression via Regulating JNK and p38 MAPK Signaling Pathways. Recent Patents Anti-Cancer Drug Discov. 2023;18:80–91. doi: 10.2174/1574892817666220524102403.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1574892817666220524102403</ArticleId><ArticleId IdType="pubmed">35611776</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang H.-L., Sun H.-F., Gao S.-P., Li L.-D., Huang S., Hu X., Liu S., Wu J., Shao Z.-M., Jin W. SSBP1 Suppresses TGFβ-Driven Epithelial-to-Mesenchymal Transition and Metastasis in Triple-Negative Breast Cancer by Regulating Mitochondrial Retrograde Signaling. Cancer Res. 2016;76:952–964. doi: 10.1158/0008-5472.CAN-15-1630.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-15-1630</ArticleId><ArticleId IdType="pubmed">26676758</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiwari N., Tiwari V.K., Waldmeier L., Balwierz P.J., Arnold P., Pachkov M., Meyer-Schaller N., Schübeler D., van Nimwegen E., Christofori G. Sox4 Is a Master Regulator of Epithelial-Mesenchymal Transition by Controlling Ezh2 Expression and Epigenetic Reprogramming. Cancer Cell. 2013;23:768–783. doi: 10.1016/j.ccr.2013.04.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccr.2013.04.020</ArticleId><ArticleId IdType="pubmed">23764001</ArticleId></ArticleIdList></Reference><Reference><Citation>Górnicki T., Lambrinow J., Mrozowska M., Podhorska-Okołów M., Dzięgiel P., Grzegrzółka J. Role of RBMS3 Novel Potential Regulator of the EMT Phenomenon in Physiological and Pathological Processes. Int. J. Mol. Sci. 2022;23:10875. doi: 10.3390/ijms231810875.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms231810875</ArticleId><ArticleId IdType="pmc">PMC9503485</ArticleId><ArticleId IdType="pubmed">36142783</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T., Wu Y., Fang Z., Yan Q., Zhang S., Sun R., Khaliq J., Li Y. Low expression of RBMS3 and SFRP1 are associated with poor prognosis in patients with gastric cancer. Am. J. Cancer Res. 2016;6:2679–2689.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5126282</ArticleId><ArticleId IdType="pubmed">27904780</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong L., Bates S., Li Y., Lin X., Wei W., Zhou X. AKT Phosphorylates FAM13A and Promotes Its Degradation via CUL4A/DDB1/DCAF1 E3 Complex. Am. J. Respir. Cell Mol. Biol. 2023;68:577–590. doi: 10.1165/rcmb.2022-0362OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2022-0362OC</ArticleId><ArticleId IdType="pmc">PMC10174174</ArticleId><ArticleId IdType="pubmed">36749583</ArticleId></ArticleIdList></Reference><Reference><Citation>Morath I., Hartmann T., Orian-Rousseau V. CD44: More than a mere stem cell marker. Int. J. Biochem. Cell Biol. 2016;81:166–173. doi: 10.1016/j.biocel.2016.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2016.09.009</ArticleId><ArticleId IdType="pubmed">27640754</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Y., Benz T.L., Long S.B. Substrate and product complexes reveal mechanisms of Hedgehog acylation by HHAT. Science. 2021;372:1215–1219. doi: 10.1126/science.abg4998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abg4998</ArticleId><ArticleId IdType="pmc">PMC8734478</ArticleId><ArticleId IdType="pubmed">34112694</ArticleId></ArticleIdList></Reference><Reference><Citation>Skoda A.M., Simovic D., Karin V., Kardum V., Vranic S., Serman L. The role of the Hedgehog signaling pathway in cancer: A comprehensive review. Bosn. J. Basic Med. Sci. 2018;18:8–20. doi: 10.17305/bjbms.2018.2756.</Citation><ArticleIdList><ArticleId IdType="doi">10.17305/bjbms.2018.2756</ArticleId><ArticleId IdType="pmc">PMC5826678</ArticleId><ArticleId IdType="pubmed">29274272</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Y., Dong J. The Hippo Signaling Pathway in Cancer: A Cell Cycle Perspective. Cancers. 2021;13:6214. doi: 10.3390/cancers13246214.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers13246214</ArticleId><ArticleId IdType="pmc">PMC8699626</ArticleId><ArticleId IdType="pubmed">34944834</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukiw W.J., Jaber V.R., Pogue A.I., Zhao Y. SARS-CoV-2 Invasion and Pathological Links to Prion Disease. Biomolecules. 2022;12:1253. doi: 10.3390/biom12091253.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom12091253</ArticleId><ArticleId IdType="pmc">PMC9496025</ArticleId><ArticleId IdType="pubmed">36139092</ArticleId></ArticleIdList></Reference><Reference><Citation>Colaizzo E., Prosperini L., Petrucci A., Perna A. Creutzfeldt–Jakob disease associated with E200K mutation and SARS-CoV-2 infection: Pure coincidence or neurodegenerative acceleration? Clin. Transl. Neurosci. 2024;8:16. doi: 10.3390/ctn8020016.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ctn8020016</ArticleId></ArticleIdList></Reference><Reference><Citation>Classen B. Possible treatments for COVID vaccine induced prion disease. Recent Adv. Clin. Trials. 2023;5:1–5.</Citation></Reference><Reference><Citation>Stefano G.B., Buttiker P., Weissenberger S., Anders M., Raboch J., Ptacek R., Kream R.M. Potential prion involvement in long COVID-19 neuropathology, including behavior. Cell. Mol. Neurobiol. 2023;43:2621–2626. doi: 10.1007/s10571-023-01342-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-023-01342-8</ArticleId><ArticleId IdType="pmc">PMC10047479</ArticleId><ArticleId IdType="pubmed">36977809</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Jaber V.R., Lukiw W.J. SARS-CoV-2, long COVID, prion disease and neurodegeneration. Front. Neurosci. 2022;16:1002770. doi: 10.3389/fnins.2022.1002770.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2022.1002770</ArticleId><ArticleId IdType="pmc">PMC9551214</ArticleId><ArticleId IdType="pubmed">36238082</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X., Jones G.W., Choy E.H., Jones S.A. The biology behind interleukin-6 targeted interventions. Curr. Opin. Rheumatol. 2016;28:152–160. doi: 10.1097/BOR.0000000000000255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000255</ArticleId><ArticleId IdType="pubmed">26751841</ArticleId></ArticleIdList></Reference><Reference><Citation>Baran P., Hansen S., Waetzig G.H., Akbarzadeh M., Lamertz L., Huber H.J., Ahmadian M.R., Moll J.M., Scheller J. The balance of interleukin (IL)-6, IL-6 center dot soluble IL-6 receptor (sIL-6R), and IL-6 center dot sIL-6R center dot sgp130 complexes allows simultaneous classic and trans-signaling. J. Biol. Chem. 2018;293:6762–6775. doi: 10.1074/jbc.RA117.001163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA117.001163</ArticleId><ArticleId IdType="pmc">PMC5936821</ArticleId><ArticleId IdType="pubmed">29559558</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthews V., Schuster B., Schütze S., Bussmeyer I., Ludwig A., Hundhausen C., Sadowski T., Saftig P., Hartmann D., Kallen K.-J., et al. Cellular Cholesterol Depletion Triggers Shedding of the Human Interleukin-6 Receptor by ADAM10 and ADAM17 (TACE) J. Biol. Chem. 2003;278:38829–38839. doi: 10.1074/jbc.M210584200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M210584200</ArticleId><ArticleId IdType="pubmed">12832423</ArticleId></ArticleIdList></Reference><Reference><Citation>Broman N., Rantasärkkä K., Feuth T., Valtonen M., Waris M., Hohenthal U., Rintala E., Karlsson A., Marttila H., Peltola V., et al. IL-6 and other biomarkers as predictors of severity in COVID-19. Ann. Med. 2021;53:410–412. doi: 10.1080/07853890.2020.1840621.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2020.1840621</ArticleId><ArticleId IdType="pmc">PMC7935117</ArticleId><ArticleId IdType="pubmed">33305624</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C., Fei D., Li X., Zhao M., Yu K. IL-6 may be a good biomarker for earlier detection of COVID-19 progression. Intensiv. Care Med. 2020;46:1475–1476. doi: 10.1007/s00134-020-06065-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06065-8</ArticleId><ArticleId IdType="pmc">PMC7206216</ArticleId><ArticleId IdType="pubmed">32385523</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimmig L.M., Wu D., Gold M., Pettit N.N., Pitrak D., Mueller J., Husain A.N., Mutlu E.A., Mutlu G.M. IL-6 inhibition in critically Ill COVID-19 patients is associated with increased secondary infections. Front. Med. 2020;7:583897. doi: 10.3389/fmed.2020.583897.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.583897</ArticleId><ArticleId IdType="pmc">PMC7655919</ArticleId><ArticleId IdType="pubmed">33195334</ArticleId></ArticleIdList></Reference><Reference><Citation>Djukic T., Stevanovic G., Coric V., Bukumiric Z., Pljesa-Ercegovac M., Matic M., Jerotic D., Todorovic N., Asanin M., Ercegovac M., et al. GSTO1, GSTO2 and ACE2 Polymorphisms Modify Susceptibility to Developing COVID-19. J. Pers. Med. 2022;12:458. doi: 10.3390/jpm12030458.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm12030458</ArticleId><ArticleId IdType="pmc">PMC8955736</ArticleId><ArticleId IdType="pubmed">35330457</ArticleId></ArticleIdList></Reference><Reference><Citation>Djukić T., Stevanović G., Ćorić V., Bukumirić Z., Plješa-Ercegovac M., Matić M., Jerotić D., Ašanin M., Ercegovac M., Ranin J., et al. The association of glutathione transferase omega polymorphisms with laboratory inflammatory parameters in COVID-19. Med. Istraz. 2022;55:59–66. doi: 10.5937/medi55-38002.</Citation><ArticleIdList><ArticleId IdType="doi">10.5937/medi55-38002</ArticleId></ArticleIdList></Reference><Reference><Citation>Segatori V.I., Garona J., Caligiuri L.G., Bizzotto J., Lavignolle R., Toro A., Sanchis P., Spitzer E., Krolewiecki A., Gueron G., et al. Effect of Ivermectin and Atorvastatin on nuclear localization of importin alpha and drug target expression profiling in host cells from nasopharyngeal swabs of SARS-CoV-2- positive patients. Viruses. 2021;13:2084. doi: 10.3390/v13102084.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13102084</ArticleId><ArticleId IdType="pmc">PMC8537229</ArticleId><ArticleId IdType="pubmed">34696514</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaidi A.K., Dehgani-Mobaraki P. The mechanisms of action of ivermectin against SARS-CoV-2—An extensive review. J. Antibiot. 2021;75:60–71. doi: 10.1038/s41429-021-00491-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41429-021-00491-6</ArticleId><ArticleId IdType="pmc">PMC8688140</ArticleId><ArticleId IdType="pubmed">34931048</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J., Luan Y., Xiang D., Tan X., Chen H., Deng Q., Zhang J., Chen M., Huang H., Wang W., et al. The 11S proteasome subunit PSME3 is a positive feedforward regulator of NF-κB and important for host defense against bacterial pathogens. Cell Rep. 2016;14:737–749. doi: 10.1016/j.celrep.2015.12.069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2015.12.069</ArticleId><ArticleId IdType="pmc">PMC4740229</ArticleId><ArticleId IdType="pubmed">26776519</ArticleId></ArticleIdList></Reference><Reference><Citation>Alfaro E., Díaz-García E., García-Tovar S., Zamarrón E., Mangas A., Galera R., López-Collazo E., García-Rio F., Cubillos-Zapata C. Upregulated proteasome subunits in COVID-19 patients: A link with hypoxemia, lymphopenia and inflammation. Biomolecules. 2022;12:442. doi: 10.3390/biom12030442.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom12030442</ArticleId><ArticleId IdType="pmc">PMC8946050</ArticleId><ArticleId IdType="pubmed">35327634</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou L., Moch C., Graille M., Chapat C. The SARS-CoV-2 protein NSP2 impairs the silencing capacity of the human 4EHP-GIGYF2 complex. iScience. 2022;25:104646. doi: 10.1016/j.isci.2022.104646.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2022.104646</ArticleId><ArticleId IdType="pmc">PMC9213009</ArticleId><ArticleId IdType="pubmed">35756894</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghemrawi R., Khair M. Endoplasmic reticulum stress and unfolded protein response in neurodegenerative diseases. Int. J. Mol. Sci. 2020;21:6127. doi: 10.3390/ijms21176127.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21176127</ArticleId><ArticleId IdType="pmc">PMC7503386</ArticleId><ArticleId IdType="pubmed">32854418</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Li S., Yu S., Yang J., Ke J., Li H., Chen H., Lu M., Sy M.-S., Gao Z., et al. Persistent ER stress causes GPI anchor deficit to convert a GPI-anchored prion protein into pro-PrP via the ATF6–miR449c-5p–PIGV axis. J. Biol. Chem. 2023;299:104982. doi: 10.1016/j.jbc.2023.104982.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2023.104982</ArticleId><ArticleId IdType="pmc">PMC10388210</ArticleId><ArticleId IdType="pubmed">37390992</ArticleId></ArticleIdList></Reference><Reference><Citation>Meares G.P., Liu Y., Rajbhandari R., Qin H., Nozell S.E., Mobley J.A., Corbett J.A., Benveniste E.N. PERK-dependent activation of JAK1 and STAT3 contributes to endoplasmic reticulum stress-induced inflammation. Mol. Cell. Biol. 2014;34:3911–3925. doi: 10.1128/MCB.00980-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00980-14</ArticleId><ArticleId IdType="pmc">PMC4187715</ArticleId><ArticleId IdType="pubmed">25113558</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan K., Fujimoto M., Takii R., Takaki E., Hayashida N., Nakai A. Mitochondrial SSBP1 protects cells from proteotoxic stresses by potentiating stress-induced HSF1 transcriptional activity. Nat. Commun. 2015;6:6580. doi: 10.1038/ncomms7580.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms7580</ArticleId><ArticleId IdType="pmc">PMC4558571</ArticleId><ArticleId IdType="pubmed">25762445</ArticleId></ArticleIdList></Reference><Reference><Citation>Machado C.F., Nagai M.H., Lyra C.S., Reis-Silva T.M., Machado A.M., Glezer I., Felicio L.F., Malnic B. Conditional deletion of Ric-8b in olfactory sensory neurons leads to olfactory impairment. J. Neurosci. 2017;37:12202–12213. doi: 10.1523/JNEUROSCI.0943-17.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0943-17.2017</ArticleId><ArticleId IdType="pmc">PMC6596823</ArticleId><ArticleId IdType="pubmed">29118104</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S., Xu C., Larrimore K.E., Ng D.T. Slp1-Emp65: A guardian factor that protects folding polypeptides from promiscuous degradation. Cell. 2017;171:346–357.e12. doi: 10.1016/j.cell.2017.08.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.08.036</ArticleId><ArticleId IdType="pubmed">28919078</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>